Lack of Cross-Hepatotoxicity between Fluconazole and Voriconazole

April 2003
Clinical Infectious Diseases;4/15/2003, Vol. 36 Issue 8, p1091
Academic Journal
No abstract available.


Related Articles

  • A Rare Case Of Candida Tenosynovitis Successful Suppressed With Voriconazole After Fluconazole Failure. Case Report And Review Of Literature. De Pooter, J.; Ommeslag, D.; Van Den Abeele, A.; Callens, S. // Internet Journal of Infectious Diseases;2013, Vol. 12 Issue 2, p1 

    A 69-year-old patient presented with a Candida albicans bilateral tenosynovitis of the extensor digitorum muscles. Haematogenous spread was most likely as no trauma for direct inoculation was apparent, while he had been treated for Candida spondylodiscitis one year before. Although initial...

  • Everolimus/fluconazole/voriconazole interaction.  // Reactions Weekly;10/11/2008, Issue 1223, p11 

    The article describes the case of a 65-year-old man who was treated to prevent the anticipated pharmacokinetic interaction between everolimus and fluconazole, and between everolimus and voriconazole. The patient was given fluconazole for duodenal perforation and everolimus for immunosuppression....

  • Budesonide/fluconazole/voriconazole interaction.  // Reactions Weekly;12/15/2012, Issue 1432, p13 

    The article describes the clinical cases of five haematopoietic stem cell transplant recipients who developed Cushing's syndrome secondary to a drug interaction between budesonide and either fluconazole or voriconazole.

  • Companion Drugs for Amphotericin B in Cryptococcal Meningitis: Flucytosine, Fluconazole, or Nothing? Bennett, John // Clinical Infectious Diseases;1/1/2012, Vol. 54 Issue 1, p129 

    The author reflects on randomized study regarding the use of flucytosine, fluconazole, and voriconazole as an alternative of amphotericin for the treatment of cryptococcal meningitis in South African retroviral-naive AIDS patients. The author argues that amphotericin B can provide the same...

  • Investigation of Association between Slime Production by Candida Spp and Susceptibility to Fluconazole and Voriconazole. Kaskatepe, Banu; Yildiz, Sulhiye // Tropical Journal of Pharmaceutical Research;Oct2013, Vol. 12 Issue 5, p821 

    Purpose: To determine the susceptibilities of fluconazole and voriconazole based on slime production by Candida spp. Methods: Candida strains (115) isolated in the period between January 2011 and January 2012 were included in this study. Conventional methods were used for the identification....

  • Fluconazole/tacrolimus/voriconazole interaction.  // Reactions Weekly;5/14/2011, Issue 1351, p23 

    The article describes the case of four patients who developed hyperglycemia, elevated creatinine and hepatotoxicity due to fluconazole, tacrolimus and voriconazole interaction.

  • Fluconazole/voriconazole.  // Reactions Weekly;Apr2015, Vol. 1546 Issue 1, p121 

    The article presents case report of a patient who developed candiduria secondary to candida resistance following therapy with fluconazole and voriconazole.

  • Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. Saari, Teijo I.; Laine, Kari; Neuvonen, Mikko; Neuvonen, Pertti J.; Olkkola, Klaus T. // European Journal of Clinical Pharmacology;Jan2008, Vol. 64 Issue 1, p25 

    Fentanyl is a widely used opioid analgesic, which is extensively metabolized by hepatic cytochrome P450 (CYP) 3A. Recent reports suggest that concomitant administration of CYP3A inhibitors with fentanyl may lead to dangerous drug interactions. The potential interactions of fentanyl with triazole...

  • In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia. Chandenier, J.; Adou-Bryn, K.D.; Douchet, C.; Sar, B.; Kombila, M.; Swinne, D.; Thérizol-Ferly, M.; Buisson, V.; Richard-Lenoble, D. // European Journal of Clinical Microbiology & Infectious Diseases;Jun2004, Vol. 23 Issue 6, p506 

    In order to determine the potential role that various antifungal agents might have in the management of cryptococcosis in tropical areas, the in vitro susceptibility of Cryptococcus neoformans isolates from Africa (n=52) and Cambodia (n=110) to three antifungal agents (amphotericin B,...

  • Antifungal susceptibility of bloodstream yeasts isolated at a public children’s hospital in Brazil: comparison of the Etest® and the AFST–EUCAST microdilution method. Matsumoto, Flávia E.; Dias, Amanda L. T.; Melhem, Márcia S. C.; Szeszs, Maria W.; Auler, Marcos E.; Ruiz, Luciana S.; Gonçalves da Silva, Ériques; Gandra, Rinaldo F.; Paula, Claudete R. // Canadian Journal of Microbiology;Dec2007, Vol. 53 Issue 12, p1300 

    This study compared the minimum inhibitory concentration (MIC) results from the proposed standard methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing (AFST–EUCAST) with the commercial system Etest® in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics